Effects of spironolactone on carbon tetrachloride hepatotoxicity.
D000410:Alanine Transaminase / Q000097:blood; D000447:Aldehydes / Q000378:metabolism; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D002252:Carbon Tetrachloride Poisoning / Q000201:enzymology; D056486:Chemical and Drug Induced Liver Injury / Q000201:enzymology / Q000517:prevention & control*; D003577:Cytochrome P-450 Enzyme System / Q000032:analysis; D003579:Cytochrome Reductases / Q000032:analysis; D003574:Cytochrome c Group; D005952:Glucose-6-Phosphatase / Q000032:analysis; D008297:Male; D008314:Malonates / Q000378:metabolism; D008862:Microsomes, Liver / Q000201:enzymology; D009249:NADP; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology*
D000447:Aldehydes; D003574:Cytochrome c Group; D008314:Malonates; D013148:Spironolactone; D009249:NADP; D003577:Cytochrome P-450 Enzyme System; D003579:Cytochrome Reductases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D005952:Glucose-6-Phosphatase